SCAPPINI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 604
EU - Europa 360
AS - Asia 112
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.080
Nazione #
US - Stati Uniti d'America 603
RU - Federazione Russa 173
IT - Italia 49
IE - Irlanda 43
HK - Hong Kong 26
CN - Cina 25
SE - Svezia 25
SG - Singapore 23
JO - Giordania 20
PL - Polonia 18
GB - Regno Unito 13
CH - Svizzera 10
IN - India 10
UA - Ucraina 9
FI - Finlandia 7
DE - Germania 6
ID - Indonesia 3
BE - Belgio 2
CI - Costa d'Avorio 2
ES - Italia 2
NL - Olanda 2
VN - Vietnam 2
CA - Canada 1
DK - Danimarca 1
EU - Europa 1
JP - Giappone 1
KR - Corea 1
SD - Sudan 1
TR - Turchia 1
Totale 1.080
Città #
Santa Clara 128
Fairfield 67
Chandler 49
Ashburn 46
Dublin 43
Seattle 28
Houston 27
Woodbridge 26
Cambridge 25
Hong Kong 21
Wilmington 21
Singapore 19
Warsaw 18
Ann Arbor 17
Altamura 14
Lawrence 14
Moscow 12
Florence 11
Princeton 11
Buffalo 9
Bern 8
Jacksonville 8
Kent 7
New York 7
Beijing 6
Boston 6
Medford 6
San Diego 6
Shanghai 6
Turin 6
Mumbai 5
Rome 4
Hillsboro 3
Malang 3
Yubileyny 3
Abidjan 2
Barcelona 2
Boardman 2
Brussels 2
Dong Ket 2
Falls Church 2
Karlskrona 2
Kolkata 2
Los Angeles 2
Manchester 2
Norwalk 2
Pune 2
Rubano 2
Southport 2
Sulmona 2
Bremen 1
Brooklyn 1
Castel Volturno 1
Copenhagen 1
Corato 1
Edinburgh 1
Gallatin 1
Glasgow 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Helsinki 1
Hounslow 1
Izmir 1
Kharkov 1
Lappeenranta 1
Obata 1
Poplar 1
Redwood City 1
Salerno 1
Seoul 1
Toronto 1
Torquay 1
Xuzhou 1
Totale 744
Nome #
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 133
Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia 132
Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients. 114
Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey 110
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. 110
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia. 109
Concomitant occurrence of BCR-ABL and JAK2V617F mutation. 99
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in AML 98
Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience 70
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia 63
Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study 54
Totale 1.092
Categoria #
all - tutte 3.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.691


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202091 0 0 0 0 14 14 14 16 14 8 7 4
2020/202187 5 8 3 14 5 8 4 8 13 9 3 7
2021/202279 9 1 7 3 3 5 3 9 1 5 13 20
2022/2023230 15 44 15 11 13 29 29 10 43 1 7 13
2023/2024129 2 6 8 10 18 19 0 27 5 6 16 12
2024/2025364 20 57 40 95 152 0 0 0 0 0 0 0
Totale 1.092